Inactive Instrument

Luckycom Inc Stock OTC Bulletin Board

Equities

US54959R1086

Investment Holding Companies

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Luckycom Inc
Managers TitleAgeSince
Chief Executive Officer 49 13-01-01
Director of Finance/CFO - 21-08-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 49 13-01-01
More insiders
Luckwel Pharmaceuticals Inc. creates medicine to cure diseases. The Company is focused on autoimmune disease, human immunodeficiency virus (HIV) / acquired immune deficiency syndrome (AIDS) and infectious diseases. The Company’s pipelines include LWEL-2120 for the treatment of rheumatoid arthritis (RA), LWEL-2119 for the treatment of HIV and LWEL-2103 for the treatment of COVID-19.
More about the company